3650 results for «415»

Filter By

3650 results

LAA Closure - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to efficiently manage LAA closure for stroke prevention, thanks to a compelling LIVE demonstration from Institut Cardiovasculaire Paris Sud, France, during EuroPCR 2019. Discover the case of a 81 years-old female with intracranial hemmorrhage  and multiple cerebral cavernomatosis; watch the treatment...

LAA Closure - LIVE Case

Transcatheter mitral valve repair for degenerative mitral regurgitation - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this live transmission from EuroPCR 2019 to discover the case of a 87 years-old female, who has been referred for degenerative mitral regurgitation. Watch it now to find out about the treatment's choice!

LIVE demonstration from Rigshospitalet, University of Copenhagen - Copenhagen, Denmark

Transcatheter mitral

Complex aortoiliac bifurcation treatment - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to select the best vascular access option (single versus multiple) and how to drive your device choice for patient-/lesion-individualised treatment.

LIVE demonstration from Clinique Pasteur - Toulouse, France

Complex aortoiliac bifurcation

EuroPCR 2019 Closing Ceremony

24 May 2019 – From EuroPCR 2019

Consult this session to discover EuroPCR 2019 Closing Ceremony, where Andreas Baumbach - president of the EAPCI - highlights the key moments of the course, and what makes it unique.
Stay put: a surprise awaits you at the end!

That year, EuroPCR gathered 11,206 active participants; warm thanks to all...

EuroPCR 2019 Closing

TAVI in horizontal aorta

22 May 2019 – From EuroPCR 2019

Consult this session to discover a LIVE demonstration from St. Johannes Hospital - Dortmund, Germany, regarding TAVI in horizontal aorta, transmitted live during EuroPCR 2019. The patient here is a 78 years-old male presenting with progressive dyspnea (NYHA III) and angina pectoris (CCS-III), whose echography shows...

TAVI in horizontal aorta

Artificially synthesized optical coherence tomography images based on intravascular ultrasound-virtual histology examination of diseased coronary artery

05 May 2021

Intravascular imaging is a cornerstone of invasive management of coronary disease, requiring specialized training to interpret either IVUS or OCT. AI can facilitate interpretation by non-specialists in real time.

AI-generated synthetic OCT

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

17 Sep 2022

Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan
Ali Nazmi Calik

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF
Didn’t find what you were looking for?